DUBLIN--(BUSINESS WIRE)--The "Patient Derived Xenograft/PDX Models Market - Global Forecast to 2022" report has been added to Research and Markets' offering.
The global PDX models market is expected to reach USD 167.6 Million by 2022 from USD 77.4 Million in 2017, at a CAGR of 16.7%.
The growth of this market is majorly driven by the growing demand for personalized medicine, continuous support for cancer research from the public as well as private sectors, and growth in the number of R&D activities in the pharmaceutical industry. However, the high cost of personalized PDX models and stringent guidelines regarding the ethical use of animals in cancer research are expected to restrain the growth of this market during the forecast period.
The report analyzes the patient derived xenograft models market by type, tumor type, application, end user, and region. On the basis of type, the market is segmented into mice and rat models. The mice models segment is estimated to command the largest share of the global market in 2017. The rat models segment, on the other hand, is projected to register the highest CAGR from 2017 to 2022. Growth in this market is mainly driven by the larger size of rats, which enhances surgical manipulation. The development of immunodeficient rats will drive the usage of rat models in PDX model generation. Based on tumor type, the PDX models market has been segmented into gastrointestinal tumor models, gynecological tumor models, respiratory tumor models, urological tumor models, hematological tumor models, and other tumor models such as head & neck tumors, sarcoma, and melanoma. In 2017, the gastrointestinal tumor models segment is expected to account for the largest share of the global market.
Companies Mentioned
- Bioduro (Us)
- Champions Oncology Inc.
- Charles River Laboratories International Inc.
- Crown Bioscience Inc.
- Epo Berlin-Buch Gmbh
- Hera Biolabs
- Horizon Discovery Group Plc (Sage Labs Inc.)
- Oncodesign
- Pharmatest Services Ltd.
- Shanghai Lide Biotech Co. Ltd. (China)
- The Jackson Laboratory
- Urolead
- Wuxi Apptec (Group of Subsidiaries Under Wuxi Pharmatec)
- Xenopat (Spain)
- Xentech
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 PDX Models Market, By Type
7 PDX Models Market, By Tumor Type
8 PDX Models Market, By Application
9 PDX Models Market, By End User
10 PDX Models Market, By Region
11 Competitive Landscape
12 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/mtggqd/patient_derived
